Navigation Links
Neogen Reactivates Share Repurchase Program

LANSING, Mich., March 9 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that on March 6 it initiated its current common stock repurchase program. In December, Neogen's Board of Directors authorized the repurchase of up to 500,000 shares.

Shares have been, and additional shares are expected to be, acquired on the open market or in negotiated transactions, depending on market conditions and other factors. Accordingly, there is no guarantee of the exact number of shares to be repurchased. Shares repurchased under the program will be retired. The company had 14,600,000 shares outstanding on Nov. 30, 2008.

"The price of Neogen shares is at the lowest level in nearly two years," said James Herbert, Neogen's CEO. "We believe the price is an extraordinary value given the company's fundamentals and performance that have withstood the worst overall economy in decades."

Neogen's second quarter was the 63rd consecutive profitable quarter from operations for the company, and the 67th quarter of the past 72 quarters to show increased revenues as compared with the previous year--a span of 18 years. Neogen will announce results for the third quarter of its 2009 fiscal year, which ended Feb. 28, on Thursday, March 19.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.

SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoGenomics to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
2. Webcast Alert: Neogen Corporation To Announce 2nd Quarter Results
3. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
4. NeoGenomics to Present at the Noble Financial Equity Conference
5. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
6. NeoGenomics Announces Results for the 3rd Quarter 2007
7. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
8. Stimulating Thymus Reactivates T-Cell Production
9. Consumer Group Wants Public to Share Profits From Federally Funded Stem Cell and Medical Research
10. Quaker Oats and Share Our Strength Announce New Movement to Fight Childhood Hunger
11. Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer
Post Your Comments:
(Date:11/27/2015)... VVA (PRWEB) , ... November 27, 2015 , ... ... motto of progress through sharing, the 2016 Building Better Radiology Marketing ... The conference will begin on Sunday, March 6, 2016, at Caesars Palace in ...
(Date:11/27/2015)... ... 2015 , ... The moment you stop improving is the ... the needs of advisers and clients but going above and beyond to find ... service. However, there's always room for improvement, which is why the entire Consulting ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... -- Lannett Company, Inc. (NYSE: LCI ) today ... Kremers Urban Pharmaceuticals Inc. (KU), the U.S. specialty ... S.A. (Euronext: UCB). --> ... UCB for total consideration of approximately US$1.23 billion, ... capital adjustment, a deduction of certain reimbursable amounts ...
(Date:11/26/2015)... 2015 Un nuevo enfoque combina ... el cáncer avanzado.   --> Un ... de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... --> Clinical Cancer Research . --> ...
(Date:11/26/2015)... 2015 --> --> ... to find optimal contrast weighting of MRI for patients ... signed a research agreement with SyntheticMR in order to use ... it is possible to generate multiple contrast images from a ... has left, thus making it possible to both fine tune ...
Breaking Medicine Technology: